Single-photon emission computed tomography (SPECT)
Showing 9976 - 10000 of >10,000
Zirconia Implants for Replacement of a Single Tooth
Active, not recruiting
- Partial-edentulism
- Dental Implant
-
Bern, SwitzerlandUniversity od Bern - Klinik für rekonstruktive Zahnmedizin und G
May 17, 2022
Safety, Tolerability, Ocular Surface Trial in Guadalajara (Bepotastine Besilate)
Completed
- Safety
- +3 more
- Bepotastine Besilate
-
Guadalajara, Jalisco, MexicoUnidad Clínica de Bioequivalencia, S. de R.L. de C.V.
Dec 22, 2021
Liver Transplant Failure and Rejection Trial in Madison (Ascorbic acid, Placebo)
Not yet recruiting
- Liver Transplant Failure and Rejection
- Ascorbic acid
- Placebo
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Jan 11, 2023
Healthy Volunteers Trial in Groningen (GYM329, Placebo)
Active, not recruiting
- Healthy Volunteers
- GYM329
- Placebo
-
Groningen, NetherlandsQPS Netherlands B.V.
Jul 5, 2022
Rib Fracture Multiple Trial (Serratus Anterior Plane Block (SAPB), Standard Analgesic Medications)
Not yet recruiting
- Rib Fracture Multiple
- Serratus Anterior Plane Block (SAPB)
- Standard Analgesic Medications
- (no location specified)
Feb 25, 2023
Human Papilloma Virus Trial in Montreal (Mouthwash gargling)
Not yet recruiting
- Human Papilloma Virus
- Mouthwash gargling
-
Montreal, Quebec, CanadaMcGill University
Feb 16, 2023
Split Dose CT Trial in Durham (Dual-source multi-detector computed tomography (DSSE))
Terminated
- Split Dose CT
- Dual-source multi-detector computed tomography (DSSE)
-
Durham, North CarolinaDuke University Medical Center
Nov 25, 2019
Biliary Tract Tumor Trial in Nanjing (Tislelizumab, Lenvatinib, Oxaliplatin)
Recruiting
- Biliary Tract Tumor
- Tislelizumab
- +3 more
-
Nanjing, Jiangsu, ChinaJiangsu Province Hospital
Mar 14, 2022
Acute Ischemic Stroke Trial (LT3001 Drug Product, Placebo)
Not yet recruiting
- Acute Ischemic Stroke
- LT3001 Drug Product
- Placebo
- (no location specified)
Jan 3, 2022
Multiple Myeloma Trial in Japan (Isatuximab SAR650984)
Completed
- Multiple Myeloma
- Isatuximab SAR650984
-
Nagoya-shi, Aichi, Japan
- +12 more
Nov 22, 2022
Acceptability of Hybrid Closed-loop Systems in Patients Living
Recruiting
- Type 1 Diabetes
- device
-
Corbeil-essonnes Cedex, Centre Hospitalier Sud Francilien, France
- +1 more
Sep 27, 2022
Nicotine Dependence Trial in Athens (Financial Incentives)
Recruiting
- Nicotine Dependence
- Financial Incentives
-
Athens, GeorgiaUniversity of Georgia
Jun 17, 2022
COPD Trial (intervention group 1, intervention group 2, intervention group 3)
Not yet recruiting
- COPD
- intervention group 1
- +4 more
- (no location specified)
Apr 13, 2022
Esophagogastric Junctional Adenocarcinoma:A Single Center,
Not yet recruiting
- Stomach Neoplasms
- An Intelligent Endoscopic Diagnosis System Developed and Verified Based on Deep Learning
- (no location specified)
Apr 6, 2023
Pediatric Hypertension Trial in Houston (NICHE method, Usual care, Amlodipine)
Completed
- Pediatric Hypertension
- NICHE method
- +5 more
-
Houston, TexasThe University of Texas Health Science Center at Houston
Aug 16, 2022
SARS-CoV-2 Trial in United States (mRNA-1273.214)
Recruiting
- SARS-CoV-2
- mRNA-1273.214
-
Montebello, California
- +6 more
Jul 28, 2022
Urinary Incontinence Trial (TENA-PROTO2)
Not yet recruiting
- Urinary Incontinence
- TENA-PROTO2
- (no location specified)
Mar 23, 2022
Diabetic Neuropathic Pain, Renal Impairment, Healthy Volunteers Trial in Miami (BAY2395840)
Not yet recruiting
- Diabetic Neuropathic Pain
- +2 more
-
Miami, FloridaClinical Pharmacology of Miami, LLC
Feb 2, 2023
The Nanowear Wearable System SimpleSense Validation Trial for
Not yet recruiting
- Right Heart Catheterization
- SimpleSense
- (no location specified)
Nov 17, 2022
Hepatic Ascites Trial in Guangdong (recombinant human serum albumin, Sodium Chloride Injection)
Recruiting
- Hepatic Ascites
- recombinant human serum albumin
- Sodium Chloride Injection
-
Guangdong, Shenzheng, ChinaShenzheng Protgen Ltd
Dec 20, 2021